Genetic counseling

Are cancers hereditary? Specialist genetic counseling investigates the predisposition to develop the disease.

Assess family history

Recent studies show that about 12% of individuals with advanced prostate cancer carry a genetic mutation, thus a hereditary condition that is passed from parents (mother/father) to offspring and has predisposed the onset of the cancer itself.

It is possible with genetic counseling to identify such families. Genetic counseling is aimed at individuals in whom on the basis of personal and/or family history, the genetic predisposition to develop prostate cancer is to be investigated.

How does it take place?

The oncology genetics clinic provides counseling and genetic testing, if appropriate, for men with prostate cancer. Genetic counseling consists of several steps in which initially the patient's personal and family medical history is reviewed, and then based on that information, the option of genetic testing and what its results might mean, if indicated, will be discussed.

If the decision is made to perform genetic testing, a DNA sample will be taken through a blood draw or saliva sample, which will be sent to a laboratory for analysis.

Once the results of the genetic test are received, the significance of the result will be discussed with the patient. Telemedicine genetic counseling visits are also available.

What is it for?

Knowing whether a man with prostate cancer carries a genetic mutation associated with inherited cancer risk can help physicians select better and more effective treatment options. In addition, the oncology genetics clinic aims to identify individuals at risk of developing cancers and design personalized prevention programs with the aim of reducing morbidity and mortality, promoting the health and well-being of the individual.

Also important, once an individual carrying a genetic mutation is diagnosed, identify family members to test them for the same reasons.

The cancer genetics outpatient clinic is part of an accredited national network coordinated by the Swiss Clinical Research Group Against Cancer (SAKK). This is an important collaboration for multidisciplinary discussions, ensuring the quality of the service and its reimbursement by health insurance companies.

The English version of this page was created with the aid of automatic translation tools and may contain errors and omissions.
The original version is the page in Italian.